Consistently, 2 weeks post-infection, the mock-vaccinated group showed equal or superior results to other groups, in terms of IFN-gamma and IL-17a (Figure 6a,b, Supplementary Materials Figures S3 and S4). The gene discussed is IL17A; the disease is infection.